Navigation

NICE issues guidance on the use of drugs for the management of insomnia

The National Institute for Clinical Excellence (NICE) has today (28 April 2004) issued guidance to the NHS in England and Wales on the use of zaleplon, zolpidem and zopiclone for the management of insomnia. The guidance recommends that hypnotic drugs should only be used in the short-term management of insomnia interfering with normal daily life.

This page was last updated: 30 March 2010

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.